Dietary levels of quinine in tonic water do not inhibit CYP2D6 in vivo

Food and Chemical Toxicology

Volumn 41, Issue 8, 2003, Pages 1199-1201

  Donovan, Jennifer L ^a   DeVane, C Lindsay ^a   Boulton, David ^a   Dodd, Seetal ^a   Markowitz, John S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cytochrome P450, CYP2D6; Human; Quinine; Tonic

Indexed keywords

CARBONATED WATER; CYTOCHROME P450 2D6; DEXTROMETHORPHAN; DEXTRORPHAN; QUININE; UNCLASSIFIED DRUG; WATER;

ADULT; ARTICLE; BEVERAGE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; FEMALE; FLUID INTAKE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; METABOLITE; MICTURITION; NORMAL HUMAN; TONIC WATER; URINALYSIS; VOLUNTEER; WATER ANALYSIS;

CINCHONA PUBESCENS;

EID: 0037493516     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(03)00112-1     Document Type: Article

References (11)

1. Ash M. and Ash A. 1995. Handbook of Food Additives. Brookfield, VM, Grower Publishing Unlimited.
2. Bloomer J.C., Woods F.R., Haddock R.E., Lennard M.S., Tucker G.T. The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. British Journal of Clinical Pharmacology. 33:1992;521-523.
3. Brasic J. Should people with nocturnal leg cramps drink tonic water and bitter lemon? Psychological Reports. 84:1999;355-367.
4. Diener H.C., Dethlefsen U., Dethlefsen-Gruber S., Verbeek P. Effectiveness of quinine in treating muscle cramps. a double-blind, placebo-controlled, parallel-group, multicentre trial International Journal of Clinical Practice. 56:2002;243-246.
5. Hoskins J., Shenfield G., Gross A. Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping. Journal of Chromatography B: Biomedical Applications. 696:1997;81-87.
6. Kobayashi S., Murray S., Watson D., Sesardic D., Davies D.S., Boobis A.R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology. 38:1989;2795-2799.
7. Liston H.L., DeVane C.L., Boulton D.W., Risch S.C., Markowitz J.S., Goldman J. Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers. Journal of Clinical Psychopharmacology. 22:2002;169-173.
8. Markowitz J.S., DeVane C.L., Boulton D.W., Carson S.W., Nahas Z., Risch S.C. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sciences. 66:2000;PL133-139.
9. Muralidharan G., Hawes E.M., McKay G., Korchinski E.D., Midha K.K. Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. European Journal of Clinical Pharmacology. 41:1991;471-474.
10. Muralidharan G., Hawes E.M., McKay G., Midha K.K. Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. Xenobiotica. 21:1991;1441-1450.
11. Steiner E., Dumont E., Spina E., Dahlqvist R. Inhibition of desipramine 2-hydroxylation by quinidine and quinine. Clinical Pharmacology & Therapeutics. 43:1988;577-581.